Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
09 août 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication...
H1 Relaunches Faculty Opinions as H1 Connect, the Online Community Where HCPs and Researchers Access the Latest Breakthroughs in Medicine and Life Sciences Research
11 juil. 2023 09h00 HE
|
H1
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global HCP, clinical, scientific, and research information, today announced the launch of H1 Connect, formerly Faculty...
Datacubed Health Announces Collaboration with Special Forces Combat Veterans to Conduct Revolutionary Post-Traumatic Stress Study
14 juin 2023 07h00 HE
|
Datacubed Health
New York, New York, June 14, 2023 (GLOBE NEWSWIRE) -- Datacubed Health, a leading provider of innovative technology solutions for clinical research, is proud to announce its partnership with...
Landmark Study Investigating Novel Alzheimer’s Biomarkers Advances to Data Analysis Stage
14 juin 2023 06h00 HE
|
Global Alzheimer's Platform Foundation
WASHINGTON, DC, June 14, 2023 (GLOBE NEWSWIRE) -- Up to 50 percent of people in the U.S. with Alzheimer’s receive an imprecise or inaccurate diagnosis of their cognitive condition. The tools...
CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends
09 juin 2023 12h54 HE
|
American College of Medical Toxicology
Phoenix, AZ, June 09, 2023 (GLOBE NEWSWIRE) -- Fentanyl, a powerful synthetic opioid, has emerged as a significant public health concern across the United States, contributing to a surge in...
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
08 juin 2023 09h00 HE
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
25 mai 2023 09h00 HE
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™
11 mai 2023 08h30 HE
|
Axis Research & Technologies
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and testing, announced the...
Viral Vector Production Market to Reach USD 17.3 Bn by 2031, growing at a CAGR of 4.4%: as per TMR Study
09 mai 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 09, 2023 (GLOBE NEWSWIRE) -- The global viral vector production market stood at USD 16.7 Bn in 2022 and is anticipated to exceed USD 17.3 Bn by 2031,...
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies
25 avr. 2023 09h07 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 25, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a leading developer of medical technologies, today announced it is moving forward in its clinical...